About half of France's coronavirus patients in intensive care are under 65, health official says
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
A French health official says warnings to stay home in the coronavirus pandemic are in some cases falling on deaf ears while noting that the virus hasn't just been posing a risk to seniors.
French health ministry official Jérôme Salomon said Monday that the situation is "deteriorating very quickly" while providing this statistic: of the between 300 and 400 coronavirus patients in intensive care in France, about half of them are younger than 65, The New York Times reports.
Salomon is looking to "dispel the notion that the virus seriously threatens only the elderly," the Times reports, and Mother Jones observes that even though the novel coronavirus is "understood to be particularly lethal among the elderly," these numbers "underscore the reality that younger generations can still face serious consequences."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Salomon also said Monday that in France, "a lot of people have not understood that they need to stay at home," and as a result, "we are not succeeding in curbing the outbreak of the epidemic," per Reuters. Most nonessential businesses in France were ordered to be closed over the weekend.
France has confirmed more than 5,400 cases of the novel coronavirus, and by Sunday, the number of deaths had risen to 127. Salomon said Monday the number of cases has been doubling "every three days."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Trump’s EPA kills legal basis for federal climate policySpeed Read The government’s authority to regulate several planet-warming pollutants has been repealed
-
Political cartoons for February 13Cartoons Friday's political cartoons include rank hypocrisy, name-dropping Trump, and EPA repeals
-
Palantir's growing influence in the British stateThe Explainer Despite winning a £240m MoD contract, the tech company’s links to Peter Mandelson and the UK’s over-reliance on US tech have caused widespread concern
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
